| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |